Business
Pace of FDA research frustrates CBD advocates
By
Alex Halperin
Jan 13, 2021
Jan 13, 2021
Share: 
A January article co-authored by U.S. Food and Drug Administration commissioner Stephen Hahn, which calls for more high-quality CBD research, is unlikely to impress many in the hemp industry. CBD advocates have long been frustrated by what they consider the...
This content is FREE for registered users.
To view this content you need to register as a Weedweek member.
If you are already a member please login below.
Share:
pro
EXCLUSIVE: Rumors swirl as brands depart Herbl
On Wednesday, the founders of California brand Kikoko sent out an email announcing they had parted ways with distributor Herbl, “effective immediately.”“While this change feels abrupt,” Jennifer Chapin and Amanda...
business
Leafly removes stories about Trulieve factory worker’s death
Web site Leafly took down two stories investigating the death of a Trulieve factory worker in Massachusetts. Lorna McMurrey, 27, died at a hospital in January 2022 after she collapsed during...
pro
Why doesn’t Calif. crack down on burner distros?
In recent weeks, a brash weed boss has alleged that Glass House, the company building California’s largest cannabis farm, is the “biggest black marketeer” in American history.In videos posted on...
